Medtronic released positive two-year trial Evolut TAVR results that demonstrated superior valve performance in small aortic annuli patients.
Recent research from Karl Landsteiner University of Health Sciences (KL Krems) provides important new insights into how ...
In patients with aortic stenosis and a small aortic annulus, results showed comparable composite outcome of mortality, disabling stroke, and heart failure hospitalization, and continued superior ...
Medical Device Network on MSN15d
Medtronic announces two-year trial outcomes of Evolut TAVRMedtronic has announced the SMART trial’s two-year outcomes of Evolut TAVR for aortic stenosis (AS) and small aortic annulus.
WASHINGTON, DC—Updated data from the SMART trial show that supra-annular self-expanding valves yield similar ... in patients with small annuli and symptomatic severe aortic stenosis. Presenting the ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial, the largest international ...
Medtronic : Data Confirms Superior Valve Performance Of Evolut TAVR System In Small Annulus Patients
In patients with aortic stenosis and a small aortic annulus, results showed comparable composite outcome of mortality, disabling stroke, and heart failure hospitalization, and continued superior ...
The preliminary results look promising for the Evolut for specific patients. The trial consists of mostly women, who have ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMa ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback